Category: Patents
-
Novo Nordisk suffers another loss in efforts to extend key Ozempic patent in Brazil
Brazil’s Superior Tribunal de Justiça has issued its first-ever decision on patent term adjustment, ruling that Novo Nordisk’s request to extend its Ozempic-related patent is unconstitutional because a drugmaker’s rights to a patent term cannot override society’s rights to affordable medicine.
-
BREAKING: Within hours of Brazilian injunction, HEVC Advance lists Hisense as licensee
The Brazilian court gave Hisense only 48 hours to comply. and a preliminary injunction based on a report by a court-appointed expert has teeth.
-
Brazilian PIs and bad-faith litigation sanctions hit Hisense; newly discovered European video lawsuits against Hisense, Disney, Rakuten, DAZN
Preliminary injunctions, a fine for bad-faith litigation, multiple new video patent lawsuits in the Unified Patent Court and Munich I Regional Court: the heat is on.
-
BREAKING: First-ever major SEP infringement suit in Morocco: Ericsson ramps up 4G, 5G SEP enforcement campaign against Transsion in Indonesia, Colombia, Morocco
Despite offering Transsion arbitration over FRAND-compliant terms, the company continues to “benefit” from Ericsson’s patented technology without a license, and “justice delayed is justice denied”, Robert Earle, Ericsson’s Vice President, Patent Assertion and Enforcement, said today.
-
High Court judge declares Acer, ASUS, Hisense entitled to interim licenses from Nokia despite arbitration offer, but Nokia will appeal
Mr Justice Mellor says he’s aware of Lord Justice Arnold’s preference for arbitration on FRAND terms, but this did not dissuade him from granting Acer, ASUS and Hisense an interim-license declaration.
-
Atlas Global suffers another blow to global WiFi 6 SEP enforcement campaign as EPO revokes key patent
The European Patent Office has revoked the last of the WiFi standard-essential patents that Atlas Global asserted against TP-Link in Germany and the Unified Patent Court.
-
Quantum-related patents increased fivefold in past decade, but high barriers to adoption: OECD-EPO report
While the number of international patent family applications has surged fivefold since 2014, 80% of companies in the sector do not have quantum as their main activity, and Europe faces notable challenges in commercializing its technology.
-
BREAKING: Chinese FRAND determination in ZTE v. Samsung could come down any day now and set new Chinese speed record
A pretrial hearing in London revealed that a Chinese FRAND determination for a ZTE-Samsung SEP license is imminent.
-
Teva removes more than 200 patents from U.S. FDA’s Orange Book: win for FTC
Following President Trump’s promise to lower the cost of drugs and a United States Federal Trade Commission investigation into a patent portfolio owned by Teva, the Israeli pharma company has asked the Food and Drug Administration to remove more than 200 improper patent listings related to asthma, diabetes, and COPD drugs, and epinephrine autoinjectors, from…

